Biomaterial products developer Ortec International has filed the final safety and efficacy data required by the Food and Drug Administration to evaluate its pre-market approval application for the use of OrCel in the treatment of venous leg ulcers.

EAST RUTHERFORD, N.J., Feb. 2 /PRNewswire-FirstCa